Prescription guides / Cost and access
Femring vs estradiol patch: systemic therapy and 90-day costs
At a glance
Femring and estradiol-only skin patches are different systemic estrogen options. A Femring ring lasts 90 days; eight twice-weekly patches cover four weeks. Compare complete prescriptions over the same period, and separate Medicare-program cash purchases from covered copays.
| Purchase detail | Femring | Estradiol patch example: Minivelle |
|---|---|---|
| Route and interval | Vaginal ring with systemic estrogen delivery; 90-day interval | Skin patch; replaced twice weekly |
| Strength | 0.05 or 0.10 mg/day estradiol equivalent | Five delivery strengths, with indication differences |
| Quantity basis | One ring | Eight patches = four weeks at labeled twice-weekly use |
| Additional medicine | Include any separately prescribed progestogen | Include any separately prescribed progestogen |
Product identity and interval sources: Femring prescribing information. Minivelle prescribing information.
Compare 90 days with 90 days—not one ring with one carton
A ring purchase and an eight-patch carton cover different intervals. Ask the pharmacy for a 90-day patch quantity and its actual dispensing units, then compare the charge with one prescribed ring. Do not divide a carton price by three or assume three cartons exactly cover 90 days.
The comparison here is with an estrogen-only patch. CombiPatch is a combined estrogen/progestin product, and cannot be inserted into the same budget without checking which other medicines the clinician would prescribe.
The Medicare offer can change the payment comparison
The Femring Medicare program advertises a conditional $190 minimum for one ring, but it requires purchases outside Part D, no reimbursement or true-out-of-pocket credit, and other enrollment conditions. It is not comparable to a patch’s covered copay without considering the benefit-year effects. Femring Medicare outside-benefit program terms.
The Minivelle price guide lists $102.52 for eight 0.05 mg/day patches, but that cash reference is not the plan’s 90-day quote. Use the product cost pages for the source details, and ask the plan to compare both options before committing to an outside-benefit program. Drugs.com: minivelle published cash-price guide.
Convenience is a medical discussion as well as a price decision
Femring’s vaginal route does not make it the same as local low-dose Estring. Ask whether systemic therapy is intended and whether a separate medicine is needed for the full regimen. For the patch, discuss skin application and adhesion concerns; for the ring, discuss comfortable use and any need for insertion assistance. Neither convenience nor price alone establishes suitability.
Questions about this decision
Is Femring a local treatment like Estring?
No. Femring provides systemic estrogen delivery and has different labeled uses.
Can I compare one ring with eight patches?
Not as equal time periods. Ask for a matched 90-day patch quote.
Does the ring price include a progestogen?
No. Include any other medicine the clinician prescribes.
Does a Medicare discount prove Femring is covered?
No. The cited program operates outside Part D and does not establish formulary coverage.
This guide helps prepare cost and coverage questions. It does not recommend starting, stopping or changing medicine. Your clinician and pharmacist should review the prescription and the full product label.
Organize your menopause budget
Use the main-site tools with your own prescription and care costs. Calculator estimates do not verify pharmacy prices or determine treatment suitability.
Explore menopause calculators →Related prescription decisions
Sources and limits
Selected source facts checked 2026-09-17. Medical facts use the linked labels; program details use the named official source. Cash-guide prices are secondary references, not verified local pharmacy quotes. No independent clinician review is claimed.
Related comparison: Climara vs Vivelle-Dot: weekly vs twice-weekly estradiol patches.